A 25-year-old man was found to have a large right adrenal mass detected by abdominal echography and computed tomography, and presented with a mild gynecomastia. Endocrine study showed increased serum concentrations and urinary excretion of estrogens and dehydroepiandorosterone sulfate (DHEA-S). The patient had no Cushingoid features but autonomous cortisol secretion, compatible with the diagnosis of subclinical Cushing's syndrome. Surgical removal of the adrenal tumor led to normalization of serum and urinary excretion of estrogens and DHEA-S. Histopathological examination revealed a high-grade adrenocortical carcinoma (ACC). The disorganized expression of all the steroidogenic enzymes in individual tumor cells was demonstrated by immunohistochemical analysis, and the abundant expression of both aromatase mRNA and insulin-like growth factor (IGF)-II mRNA was shown by RT-PCR. These data suggest the excessive secretion of estrogen as well as the ineffective steroidogenesis by the adrenal tumor. This is a very rare case of estrogen-secreting ACC associated with subclinical Cushing's syndrome.
ADRENOCORTICAL carcinoma (ACC) is a rare malignancy associated with poor prognosis [1, 2] . Clinical and pathological feature as well as its approach to therapy is hampered by its low incidence (1-2/1,000,000/year) and heterogeneity [1, 2] . Tumors may be functional or nonfunctional depending on whether they produce biological active steroids, such as cortisol, aldosterone, androgens or estrogens. Disorganized expression of steroidogenic enzymes in individual carcinoma cells is considered to lead to ineffective corticosteroidogenesis, characteristic of altered steroid metabolism in ACC [3, 4] . We report herein a very rare case of estrogen-secreting ACC associated with subclinical Cushing's syndrome in whom detailed analysis by endocrinological, biochemical, immunohistochemical, and pathological studies was conducted.
Methods

Immunohistochemistry
Immunohistochemical analysis of steroidogenic enzymes, including cholesterol side chain cleavage (P-450 scc ), 3b-hydroxysteroid dehydrogenase (3b-HSD), 21-hydroxylase (P-450 C21 ), 11b-hydroxylase (P-450 11b ), 17a-hydroxylase (P-450 17a ), and dehydroepiandrosterone sulfotransferase (DHEA-ST) was performed on routinely processed formalin-fixed, paraffin-embedded serial sections, using the biotin-streptavidin amplified method (Nichirei, Tokyo, Japan). Immunostaining procedure and characterization of primary antibodies used in the preset study have been described previously [5] [6] [7] .
Real-time RT-PCR for aromatase (P-450 aroma ) and insulin-growth factor (IGF)-II P-450 aroma and IGF-II mRNA levels were quantified by real-time quantitative RT-PCR using fluorescent SYBR Green technology (LightCycler; Roche Molecular Biochemicals, Mannheim, Germany), as described previously [8] . Total RNA extraction from the surgically resected tumor and first-strand cDNA synthesis was performed as described previously [9] . PCR primers were designed as following; forward primer 5'-GTGGACGTGTTGACCCTTCT-3' and reverse primer 5'-CACGATAGCACTTTCGTCCA-3' for human P-450 aroma , forward primer 5'-TGACCTCATTTCCCG ATACC-3' and reverse primer 5'-GGGGAGAATT CGTCTGATTG-3' for human IGF-II. The reaction produced 90 bp products for P-450 aroma and 110 bp products for IGF-II. Total RNAs extracted from tumor tissues from each one aldosterone-producing adenoma and cortisol-producing adenoma were also analyzed for P-450 aroma and IGF-II mRNA quantification as reference.
Urinary estrogen profile by gas chromatography/mass spectrometry (GC/MS) Urinary estrogens (estrone, estradiol, estriol) concentrations of 24 h-urine collection were determined by gas chromatography/mass spectrometry (GC/MS) method as previously reported [10, 11] . The reference values of urinary estrogens concentrations from 39 healthy men (age between 18 and 49 years old) were as follows: estrone (0-10 mg/g creatinine), estradiol (0-4 mg/g creatinine), and estriol (0-10 mg/g creatinine), respectively. lactin were elevated, cortisol, testosterone, LH and FSH levels were normal, but ACTH and hCG levels were undetectable. 24 hour-urinary excretion of cortisol, 17-KS, 17-OHCS, estrone, estradiol, estriol, pregnandiol and pregnantriol were all increased. Examination of hypothalamo-pituitary-adrenal axis ( Fig. 1 ) revealed a lack of circadian rhythm of cortisol, non-suppressibility to low-and high-doses (1, 2, 8 mg) dexamethasone, unresponsiveness of ACTH and/or cortisol to CRH stimulation, and no response of cortisol to ACTH stimulation. These endocrine data are consistent with subclinical Cushing's syndrome.
Case Report
Computerized tomography (CT) and magnetic resonance imaging (MRI) of the abdomen revealed a huge (8.5 × 7.0 × 6.5 cm), heterogeneous right adrenal mass with possible central hemorrhagic necrosis (Fig. 2a-c) ; the mass displaced the liver and the kidney without an apparent evidence of infiltration or distant metastases.
[ 131 I]-Adosterol adrenal scintigraphy showed mild increase of radioisotope uptake by the right adrenal gland without a distinct uptake by the left adrenal gland (Fig.  2d) . These imaging data are compatible with ACC.
In February 2005, he underwent complete right adrenalectomy and partial resection of liver by a transperitoneal approach. Postoperative course was uneventful. Postoperative plasma estradiol level and urinary excretion of estrogens (estrone, estradiol, estriol) decreased to undetectable ranges. Low-dose (1 mg) dexamethasone suppression test showed normal cortisol suppression, but low cortisol response to ACTH stimulation. Replacement therapy with hydrocortisone (20 mg) was substituted. After discharge, his gynecomastia and mild hyperprolactinemia gradually disappeared about 3 months after surgery, and replacement of hydrocortisone was stopped. He received adjunctive chemotherapy (etoposide plus cisplatin) without mitotane in combination with external radiation using Lineac.
Histopathological study
The resected adrenal tumor weighing 330 g, was 9.0 × 8.5 × 6.0 cm in size; it was brown-yellow, wellencapsulated, and unlobulated, accompanied by a com- pressed atrophic non-neoplastic adrenal gland (Fig. 3) . Histologically, the tumor tissue consisted of disorderly solid growth pattern of compact cells with pleomorphic nuclei. Mitotic figures were easily identifiable (1-2/ HPF) (Fig. 3b, c) . Both Ki67 and p53 index were 13% and 11%, respectively (Fig. 4a, b) . The histological findings fulfilled at least seven of the Weiss's criteria for the histopathological diagnosis of ACC [11] : the presence of necrosis, diffuse architecture, high compact cells rate, high nuclear grade, high mitotic rate, sinusoidal invasion, and capsular invasion.
Immunohistochemical study
Immunohistochemical evaluation of steroidogenic enzymes revealed that immunoreactivities of all the steroidogenic enzymes (P-450 scc , P-450 C21 , 3b-HSD, P-450 17a , P-450 11b , DHEA-ST) examined were detected in the tumor cells to a varying degree (Fig. 5 ): diffuse and weak immunostaining for P-450 scc , P-450 C21 , and P-450 11b (Fig. 5a-c) ; focally and intensely staining for P-450 17a (Fig. 5d) ; diffuse and intense staining for DHEA-ST (Fig. 5e) ; intense and scattered staining for 3b-HSD (Fig. 5f ). These immunohistochemical features are consistent with the disorganized expression of steroidogenic enzymes in individual carcinoma cells, as described previously [3, 4] . Immunoreactivity of PRL was not detected in the tumor cells (data not shown).
Measurement of mRNA for P-450 aroma and IGF-II
Real-time quantitative RT-PCR for P-450 aroma and IGF-II revealed that the adrenal tumor tissue from the present case expressed far greater P-450 aroma mRNA (more than 600 times) and IGF-II mRNA (more than 400 times) than those of other hormone-producing tumors (aldosterone-producing adenoma and cortisolproducing adenoma) used as references (Fig. 6) . 
Discussion
ACC is a very rare tumor accounting only for 0.05-0.2% of all malignancies, some of which are functional with regard to steroid hormone synthesis [1, 2] . Among 73 ACC cases previously reported from the Memorial Sloan-Kettering Clinical Center, 60% were proven to be functional in whom 73% are associated with Cushing's syndrome and/or virilization, and only 2% with feminization [13] . Accordingly, Cushing's syndrome with or without virilization due to excessive androgens is relatively common in functional ACC, however, estrogen-secreting ACC with feminization is quite rare. Although the rate of subclinical Cushing's syndrome in ACC has not been well studied so far, the recent survey of 1004 cases of adrenal incidetaloma by the Italian Society of Endocrinology revealed 4 cases subclinical Cushing's syndrome out of 47 ACC cases (8.5%) [14] . The criteria of Weiss have been extensively used to differentiate between benign and malignant adrenal tumors [12] , and generally established as the only reliable method of discerning malignancy of the adrenocortical tumors. Immunohistochemical analyses of certain proliferation markers, such as p53 and Ki-67, have been demonstrated useful diagnostic markers for ACC: both proliferation indices are less than 10% in benign adrenal tumor, and correlates positively with malignant behavior in ACC [15, 16] . High index greater 10% for both Ki67 and p53 in the present tumor indicates malignancy with its highly proliferative character.
It has been shown that ACC is associated with IGF-II overexpression in the tumor tissue [17, 18] , and the recent microarray analysis have revealed that gene expression profile of IGF-II cluster in adrenal tumor tissue showed strong predictive value for the diagnosis of ACC [19] . From the present quantitative RT-PCR of IGF-II mRNA expression in the adrenal tumors, we found that steady-state IGF-II mRNA levels in the present adrenal tumor are far greater than those in two different functional (cortisol-and aldosteronesecreting) and benign adrenocortical tumors. These results strongly suggest that the expression of IGF-II mRNA by the tumor serves as a helpful diagnostic marker for ACC.
The present case with gynecomastia was shown to have increased serum and urinary excretion of estrogens and mild hyperprolactinemia. Plasma PRL levels became normalized as gynecomastia gradually disappeared postoperatively and the possible ectopic production of PRL by the tumor was excluded from the immunocytochemical study. Thus, his mild hyperprolactinemia seems likely due to nonspecific nipple stimulation of his tender gynecomastia.
Estrogens are synthesized by P-450 aroma through the conversion of androstenedione, testosterone, and 16a-hydroxyandorostenedione to estrone, estradiol, and estriol, respectively. This conversion occurs physiologically at ovary and adipose tissue, while normal adrenal cortex possesses very low levels of P-450 aroma activity [20] . We confirmed the extremely higher expression of P-450 aroma mRNA in the present tumor than that of benign functional adrenocortical tumors. Fur- thermore, the urinary analysis of estrogens excretion revealed that estrone is the major estrogens in the present case. Although possible conversion from adrenal androgens to estrogens may take place in peripheral tissue, it is most likely that androstenedione produced by the tumor is directly converted to estrone by the tumor-derived P-450 aroma . By contrast, increased circulating estradiol may be derived from the conversion of estrone via peripheral 17b-hydroxysteroid dehydrogenase type 1 [21] , because plasma testosterone levels were within normal range. Autonomous cortisol production without clinically overt Cushing's syndrome, termed as subclinical Cushing's syndrome, accounts for 5-12% of adrenal incidentaloma [14, [22] [23] [24] . However, ACC associated with subclinical Cushing's syndrome has rarely been reported thus far [25, 26] . The diagnosis of subclinical Cushing's syndrome in the present case was made by the lack of Cushingoid feature and the following endocrine data; 1) suppression of plasma ACTH; 2) lack of circadian rhythm of cortisol; 3) no response of plasma ACTH and cortisol to CRH stimulation; 4) nonsuppressibility of cortisol to low-and high-dose (1, 2, 8 mg) dexamethasone, and 5) postoperative adrenal insufficiency necessiating cortisol replacement [25] .
Immunohistochemical study of steroidogenic enzymes demonstrated that the immunoreactivities of 3b-HSD was only detected in scattered tumor cells, while those of P-450 11b was diffusely but weakly detected in most tumor cells, suggesting the ineffective corticosteroidogenesis by the tumor. This may in part explain the autonomous, but relatively low cortisol production, possibly due to the altered expression of steroidogenic enzymes in individual tumor cells [3] . Alternatively, defective expression of cytoplasmic steroid transporter proteins, such as steroidogenic acute regulatory protein, and/or altered membrane receptors, such as lowdensity lipoprotein receptor and ACTH receptor, resulting from malignant transformation may partly account for the ineffective corticosteroidogenesis by the tumor. Estrogen-secreting ACC is very rare worldwide [1, 2] , and only four cases have been reported in Japan thus far [27] [28] [29] [30] . Thus, our case adds to the literature the fifth one. As summarized in Table 2 , they are 4 male and 1 female, with the age ranging from 18-month-old to 37-year-old; all 5 cases presented with gynecomastia, 3 with virilization and none with Cushing's syndrome.
In summary, we presented a rare case of estrogensecreting ACC with subclinical Cushing's syndrome. Data from endocrinological, pathological, immunohistochemical and biochemical studies in this case suggest the excessive secretion of estrogens derived from conversion of adrenal androgens by the overexpressed P450 aroma as well as the low efficiency of cortisol production possibly due to ineffective steroidogenesis by the tumor. 
